Syndax Pharmaceuticals | ARS:年度报告
04/02 16:37 (美东)
Syndax Pharmaceuticals | DEF 14A:股东委托书决议
04/02 16:18 (美东)
Syndax Pharmaceuticals | DEFA14A:其他
04/02 16:05 (美东)
Syndax Pharmaceuticals | 8-K:重大事件
03/18 07:14 (美东)
Syndax Pharmaceuticals | 10-K:年度报表
02/27 22:50 (美东)
Syndax Pharmaceuticals | S-3ASR:“知名成熟发行人”证券注册声明
02/27 17:32 (美东)
Syndax Pharmaceuticals | S-8:员工福利计划证券登记
02/27 17:28 (美东)
Syndax Pharmaceuticals | 8-K:Syndax Pharmicals公布2023年第四季度和全年财务业绩,并提供临床和业务最新情况
02/27 16:09 (美东)
Syndax Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Kynam Capital Management, LP(6.67%),Kynam Capital Management GP, LLC(6.67%)等
02/14 12:53 (美东)
Syndax Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Point72 Asset Management, L.P.(3.3%),Point72 Capital Advisors, Inc.(3.3%)等
02/14 07:06 (美东)
Syndax Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Avidity Partners Management LP(4.7%),Avidity Partners Management (GP) LLC(4.7%)等
02/13 21:46 (美东)
Syndax Pharmaceuticals | SC 13G:超过5%持股股东披露文件-The Vanguard Group(5.11%)
02/13 17:27 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-高管 Metzger Michael A
02/09 16:12 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-高管 Goldan Keith A.
02/09 16:12 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-高管 Gallagher Neil
02/09 16:12 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-董事 Legault Pierre
02/09 16:06 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-董事 Podlesak Dennis
02/09 16:06 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-董事 Morrison Briggs
02/09 16:06 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-董事 Meury William
02/09 16:06 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-董事 Katkin Keith
02/09 16:06 (美东)
暂无数据
暂无数据